Priority Date: 19.07.12 (US 201261673514P)

DIFLUOROLACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASE AND CONDITIONS

  • Application ID: EP13745744
  • Status: PATENT GRANTED

Attorney

operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 186 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 19.07.2012 - Priority Date (US 201261673514P)
  • 23.01.2014 - Publication A1 (WO2014015247)
  • 27.05.2015 - Publication A1 (EP2875022)
  • 12.10.2016 - Publication B1 (EP2875022)